Evidence for a role of immunoproteasomes in regulating cardiac muscle mass in diabetic mice.

[1]  Xiuhua Wang,et al.  Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. , 2009, American journal of physiology. Heart and circulatory physiology.

[2]  E. Abel,et al.  Rodent models of diabetic cardiomyopathy , 2009, Disease Models & Mechanisms.

[3]  Y. Pinto,et al.  Avoidance of Transient Cardiomyopathy in Cardiomyocyte-Targeted Tamoxifen-Induced MerCreMer Gene Deletion Models , 2009, Circulation research.

[4]  J. Lagirand-Cantaloube,et al.  Inhibition of Atrogin-1/MAFbx Mediated MyoD Proteolysis Prevents Skeletal Muscle Atrophy In Vivo , 2009, PloS one.

[5]  P. Ping,et al.  Contrasting Proteome Biology and Functional Heterogeneity of the 20 S Proteasome Complexes in Mammalian Tissues*S , 2009, Molecular & Cellular Proteomics.

[6]  L. Becker,et al.  Ischemic preconditioning‐induced cardioprotection is lost in mice with immunoproteasome subunit low molecular mass polypeptide‐2 deficiency , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[7]  C. Slaughter,et al.  Differential Roles of the COOH Termini of AAA Subunits of PA700 (19 S Regulator) in Asymmetric Assembly and Activation of the 26 S Proteasome* , 2008, Journal of Biological Chemistry.

[8]  Jie Du,et al.  Cardiac muscle protein catabolism in diabetes mellitus: activation of the ubiquitin-proteasome system by insulin deficiency. , 2008, Endocrinology.

[9]  S. Vatner,et al.  Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload. , 2008, American journal of physiology. Heart and circulatory physiology.

[10]  M. Crackower,et al.  Loss of PTEN attenuates the development of pathological hypertrophy and heart failure in response to biomechanical stress. , 2008, Cardiovascular research.

[11]  Yifan Cheng,et al.  Mechanism of gate opening in the 20S proteasome by the proteasomal ATPases. , 2008, Molecular cell.

[12]  N. Maulik,et al.  Upregulation of myocardial 11S-activated proteasome in experimental hyperglycemia. , 2008, Journal of molecular and cellular cardiology.

[13]  C. Patterson,et al.  Into the heart: the emerging role of the ubiquitin-proteasome system. , 2006, Journal of molecular and cellular cardiology.

[14]  T. Lüscher,et al.  Diabetes Promotes Cardiac Stem Cell Aging and Heart Failure, Which Are Prevented by Deletion of the p66shc Gene , 2006, Circulation research.

[15]  S. Matalon,et al.  Upregulation of immunoproteasomes by nitric oxide: potential antioxidative mechanism in endothelial cells. , 2006, Free radical biology & medicine.

[16]  A. Goldberg,et al.  The FOXO3a Transcription Factor Regulates Cardiac Myocyte Size Downstream of AKT Signaling* , 2005, Journal of Biological Chemistry.

[17]  S. Heximer,et al.  G-protein signaling participates in the development of diabetic cardiomyopathy. , 2004, Diabetes.

[18]  E. Stadtman,et al.  Inhibition of apoptosis in acute promyelocytic leukemia cells leads to increases in levels of oxidized protein and LMP2 immunoproteasome. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Thomas H Marwick,et al.  Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications. , 2004, Endocrine reviews.

[20]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[21]  C. Kahn,et al.  Regulation of Myocardial Contractility and Cell Size by Distinct PI3K-PTEN Signaling Pathways , 2002, Cell.

[22]  Lance F. Barton,et al.  Regulation of Immunoproteasome Subunit Expression In Vivo Following Pathogenic Fungal Infection1 , 2002, The Journal of Immunology.

[23]  J. Robbins,et al.  The Tumor Suppressor Gene PTEN Can Regulate Cardiac Hypertrophy and Survival* , 2001, The Journal of Biological Chemistry.

[24]  G. Stark,et al.  How Stat1 mediates constitutive gene expression: a complex of unphosphorylated Stat1 and IRF1 supports transcription of the LMP2 gene , 2000, The EMBO journal.

[25]  P. Kloetzel,et al.  Efficient Generation of a Hepatitis B Virus Cytotoxic T Lymphocyte Epitope Requires the Structural Features of Immunoproteasomes , 2000, The Journal of experimental medicine.

[26]  B. Dahlmann,et al.  Alterations of proteasome activities in skeletal muscle tissue of diabetic rats , 1999, Molecular Biology Reports.

[27]  Soldano Ferrone,et al.  Different Requirements for Signal Transducer and Activator of Transcription 1α and Interferon Regulatory Factor 1 in the Regulation of Low Molecular Mass Polypeptide 2 and Transporter Associated with Antigen Processing 1 Gene Expression* , 1998, The Journal of Biological Chemistry.

[28]  L. Kaer,et al.  Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. , 1998 .

[29]  S. Tonegawa,et al.  Altered peptidase and viral-specific T cell response in LMP2 mutant mice. , 1994, Immunity.

[30]  A. Goldberg,et al.  Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[31]  A. Goldberg,et al.  Regulation of different proteolytic pathways in skeletal muscle in fasting and diabetes mellitus. , 1994, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[32]  D. Levy,et al.  The epidemiology of heart failure: the Framingham Study. , 1993, Journal of the American College of Cardiology.

[33]  J. Monaco,et al.  Homology of proteasome subunits to a major histocompatibility complex-linked LMP gene , 1991, Nature.

[34]  S. Beck,et al.  A proteasome-related gene between the two ABC transporter loci in the class II region of the human MHC , 1991, Nature.

[35]  J. McNeill,et al.  A Functional and Ultrastructural Analysis of Experimental Diabetic Rat Myocardium: Manifestation of a Cardiomyopathy , 1985, Diabetes.

[36]  W. Kannel,et al.  Role of diabetes in congestive heart failure: the Framingham study. , 1974, The American journal of cardiology.

[37]  G. Semenza,et al.  Complete loss of ischaemic preconditioning-induced cardioprotection in mice with partial deficiency of HIF-1 alpha. , 2008, Cardiovascular research.